TARA Protara Therapeutics, Inc. - Common Stock
$4.08
가격 · 8월 19, 2026
기준 재무 정보 8월 11, 2026
52주 범위
$3–$8
23% of range
애널리스트 평점
BUY
14 analysts
목표 주가
$27
+552% upside
P/E (TTM)
-3.0
ROE
-33.7%
순이익률
—
Protara Therapeutics, Inc. - Common Stock 정보 위키백과 회사 개요
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
더 보기
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Company History
Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks, Vectis Life Sciences and Intersouth Partners. They have invested over $72 million in the company.
The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing.
On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million. The company went public in 2014.
In September 2019, Proteon Therapeutics merged with ArTara Therapeutics.
PRT-201
Proteon is developing PRT-201 (vonapanitase), a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). PRT-201 is a recombinant human elastase manufactured for Proteon by Lonza.
In September 2008, the company announced that the Food and Drug Administration had granted fast track status to PRT-201.
In December 2016, they announced that the phase III trial of PRT-201 hadn't reached its primary endpoint, causing Proteon's stock price to drop more than 75%.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
TARA 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$4.08
시가총액
$218M
P/E (TTM)
-3.0
EPS (TTM)
$-1.34
매출 (TTM)
—
배당 수익률
—
ROE
-33.7%
부채/자본
—
52주 범위
$3 – $8
TARA 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
EPS
$-1.34
2021-12-31
→
2025-12-31
잉여현금흐름
$-56M
2016-12-31
→
2025-12-31
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
TARA
동종업계 중앙값
P/E (TTM)
-3.0
88.5
P/B
1.1
3.6
Price / FCF (주가 / FCF)
-3.9
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
TARA
동종업계 중앙값
ROA
-29.4%
-38.8%
ROE
-33.7%
-61.0%
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
TARA
동종업계 중앙값
Current Ratio (유동비율)
14.6
3.9
Quick Ratio (당좌 비율)
14.2
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
TARA
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
TARA
동종업계 중앙값
TARA 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
14 명의 애널리스트
- 적극 매수 3 21.4%
- 매수 10 71.4%
- 보유 1 7.1%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
7 명의 애널리스트 · 2026-08-13
중앙값
$26.00
평균
$26.57
← 모든 목표가 하회
$4.08
저가
$24.00
고가
$30.00
중앙값 목표
$26.00
+538.0%
평균 목표
$26.57
+552.1%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.07%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.31 | $-0.38 | 0.07% |
| 2025년 12월 31일 | $-0.37 | $-0.33 | -0.04% |
| 2025년 9월 30일 | $-0.31 | $-0.39 | 0.08% |
| 2025년 6월 30일 | $-0.35 | $-0.41 | 0.06% |
| 2025년 3월 31일 | $-0.29 | $-0.46 | 0.17% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| R&D Expense | $43M | $32M | $25M | $17M | $21M | $12M | $4M | $12M | $22M | $19M | $12M | $6M | |
| SG&A Expense | $22M | $17M | $19M | $21M | $26M | $22M | $4M | $10M | $9M | $10M | $8M | $4M | |
| Operating Expenses | $65M | $49M | $44M | $67M | $47M | $34M | $8M | $21M | $30M | $29M | $21M | $11M | |
| Operating Income | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-8M | |
| Interest Expense | · | · | · | · | $0 | $34.0K | · | · | · | · | · | $857.0K | |
| Interest Income | $6M | $4M | $3M | $1M | $237.0K | $500.0K | · | · | · | · | · | · | |
| Other Non-op | $7M | $5M | $3M | $1M | $237.0K | $466.0K | · | $207.0K | $139.0K | $-14.0K | $-651.0K | $5M | |
| Pretax Income | $57M | $45M | · | · | · | · | $-15M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $-110.0K | |
| Net Income | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| EPS (Basic) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| Shares (Basic) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | 11,232,576 | · | · | · | · | · | · | · | |
| EBITDA | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-15M | · | · | $-29M | $-21M | $-8M |
대차대조표 23
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $163M | $40M | $24M | $36M | $169M | $564.0K | $19M | $21M | $36M | $40M | $69M | |
| Short-term Investments | $106M | $7M | $26M | $60M | $56M | · | · | $2M | $21M | $5M | $25M | $15M | |
| Prepaid Expense | $4M | $2M | $3M | $2M | $2M | $787.0K | $78.0K | $1M | $1M | $1M | $1M | $1M | |
| Other Current Assets | $65.0K | $2.0K | $37.0K | $127.0K | $34.0K | $52.0K | · | · | · | · | · | · | |
| Current Assets | $160M | $172M | $69M | $86M | $93M | $169M | $764.0K | $23M | $43M | $43M | $67M | $85M | |
| PP&E (Net) | $759.0K | $1M | $1M | $2M | $2M | $1M | $459.0K | $263.0K | $259.0K | $372.0K | $224.0K | $83.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $1M | $475.0K | $1M | $971.0K | $937.0K | $665.0K | $467.0K | |
| Accum. Depreciation | $1M | $1M | $824.0K | $483.0K | $236.0K | $119.0K | $16.0K | $827.0K | $712.0K | $565.0K | $441.0K | $384.0K | |
| Goodwill | · | · | · | · | $30M | $30M | · | · | · | · | · | · | |
| Other Non-current Assets | $20.0K | $27.0K | $11.0K | $16.0K | $865.0K | $1M | · | · | $218.0K | $393.0K | $706.0K | $114.0K | |
| Total Assets | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Accounts Payable | $3M | $4M | $2M | $2M | $954.0K | $914.0K | $716.0K | $441.0K | $291.0K | $556.0K | $1M | $917.0K | |
| Accrued Liabilities | $6M | $5M | $3M | $3M | $2M | $2M | $3M | $3M | $9M | $5M | $3M | $1M | |
| Current Liabilities | $11M | $11M | $6M | $6M | $4M | $3M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Capital Leases | $2M | $3M | $4M | $5M | $6M | $999.0K | · | · | · | · | · | · | |
| Total Liabilities | $13M | $14M | $11M | $11M | $11M | $4M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Common Stock | $54.0K | $35.0K | $11.0K | $11.0K | $11.0K | $11.0K | $3.0K | · | $18.0K | $17.0K | $16.0K | $16.0K | |
| Paid-in Capital | $499M | $412M | $269M | $263M | $256M | $246M | $11M | $209M | $203M | $198M | $195M | $192M | |
| Retained Earnings | $-302M | $-245M | $-200M | $-160M | $-94M | $-47M | $-13M | $-210M | $-190M | $-160M | $-131M | $-110M | |
| AOCI | $90.0K | $2.0K | $-31.0K | $-688.0K | $-211.0K | · | $3.0K | $5.0K | $-14.0K | · | $-11.0K | $-6.0K | |
| Stockholders' Equity | $196M | $167M | $68M | $102M | $162M | $199M | $-2M | $5M | $35M | $38M | $63M | $82M | |
| Liabilities + Equity | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Shares Outstanding | 53,587,260 | 35,044,772 | 11,364,903 | 11,267,389 | 11,235,731 | 11,211,840 | 2,627,533 | 481,091 | 17,674,729 | 16,603,559 | 16,501,500 | 16,448,455 |
현금 흐름 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $123.0K | $57.0K | $30.0K | |
| Stock-based Comp | $4M | $4M | $6M | $7M | $10M | $10M | $424.0K | $3M | $3M | $3M | $2M | $459.0K | |
| Deferred Tax | $-11M | $-20M | $-14M | $-9M | $-5M | $-9M | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $1M | $2M | $-7M | |
| Operating Cash Flow | $-56M | $-36M | $-38M | $-26M | $-35M | $-23M | $-5M | $-23M | $-22M | $-24M | $-18M | $-10M | |
| CapEx | $94.0K | $63.0K | $45.0K | $120.0K | $596.0K | $884.0K | $475.0K | $119.0K | $35.0K | $271.0K | $198.0K | $51.0K | |
| Investing Cash Flow | $-139M | $19M | $53M | $15M | $-98M | $3M | $-475.0K | $18M | $-16M | $20M | $-11M | · | |
| Stock Issued | · | · | · | · | · | $74M | · | · | · | · | · | $62M | |
| Stock Repurchased | · | · | $91.0K | $90.0K | $228.0K | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $-91.0K | $-90.0K | $-228.0K | $66M | · | · | · | · | · | $62M | |
| Financing Cash Flow | $83M | $140M | $-91.0K | $-90.0K | $-228.0K | $189M | $500.0K | $3M | $23M | $208.0K | $163.0K | · | |
| Net Change in Cash | · | · | · | · | · | · | $-13M | $-2M | $-15M | $-4M | $-29M | $66M | |
| Free Cash Flow | $-56M | $-36M | $-38M | $-27M | $-35M | $-24M | $-16M | · | · | $-24M | $-18M | $-10M |
수익성 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -257.1% | |
| Net Margin | · | · | · | · | · | -7291.4% | · | · | · | · | · | -113.4% | |
| EBITDA Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -256.1% | |
| ROA | -29.4% | -34.2% | -42.0% | -46.1% | -25.1% | -33.2% | -98.3% | · | · | -51.4% | -28.1% | -7.4% | |
| ROE | -33.7% | -35.8% | -55.6% | -54.7% | -28.4% | -17.2% | -449.1% | · | · | -56.0% | -29.3% | 37.0% |
유동성 및 지급능력 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 | 58.1 | 12.0 | · | · | 8.4 | 16.1 | 36.2 | |
| Quick Ratio | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 | 57.8 | 10.6 | · | · | 8.1 | 15.8 | 35.8 | |
| Interest Coverage | · | · | · | · | · | -1013.1 | · | · | · | · | · | -8.8 |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | 0.1 |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Net Income TTM | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Market Cap | $286M | $185M | $21M | $30M | $76M | $271M | $9M | · | · | $1.26B | $10.24B | $6.84B | |
| P/E | -4.0 | -2.4 | -0.5 | -0.5 | -1.6 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 2321.1 | |
| P/B | 1.5 | 1.1 | 0.3 | 0.3 | 0.5 | 1.4 | 1.4 | · | · | 32.8 | 161.5 | 83.0 | |
| P / Tangible Book | 1.5 | 1.1 | 0.3 | 0.3 | 0.6 | 1.6 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.6 | -0.6 | · | · | -53.3 | -582.8 | -684.9 | |
| P / FCF | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.2 | -0.6 | · | · | -52.7 | -576.3 | -681.5 | |
| Earnings Yield | -25.1% | -41.1% | -190.4% | -218.7% | -62.4% | · | · | · | · | · | · | · |
손익계산서 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $17M | $14M | $13M | $10M | $11M | $9M | $9M | $8M | $6M | $8M | $6M | $6M | $7M | $5M | $5M | $3M | |
| SG&A Expense | $6M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Operating Expenses | $23M | $20M | $19M | $15M | $17M | $14M | $14M | $12M | $11M | $12M | $11M | $11M | $12M | $10M | $40M | $8M | |
| Operating Income | $-23M | $-20M | $-19M | $-15M | $-17M | $-14M | $-14M | $-12M | $-11M | $-12M | $-11M | $-11M | $-12M | $-10M | $-40M | $-8M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Net Income | $-22M | $-18M | $-17M | $-13M | $-15M | $-12M | $-13M | $-11M | $-10M | $-11M | $-10M | $-10M | $-11M | $-9M | $-39M | $-8M | |
| EPS (Basic) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| EPS (Diluted) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| Shares (Basic) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| Shares (Diluted) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| EBITDA | $-23M | $-20M | · | $-15M | $-17M | $-14M | · | $-12M | $-11M | $-12M | · | $-11M | $-12M | $-10M | · | $-8M |
대차대조표 23
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $15M | $50M | $13M | $31M | $91M | $163M | $52M | $90M | $52M | $40M | $34M | $34M | $21M | $24M | $47M | |
| Short-term Investments | $125M | $121M | $106M | $120M | $91M | $33M | $7M | $30M | · | $3M | $26M | $40M | $46M | $66M | $60M | $49M | |
| Prepaid Expense | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $4M | $3M | $3M | $3M | $4M | $4M | $8M | $2M | $2M | |
| Other Current Assets | $230.0K | $17.0K | $65.0K | $218.0K | $78.0K | $16.0K | $2.0K | $3.0K | $4.0K | $3.0K | $37.0K | $2.0K | $1.0K | $127.0K | $127.0K | · | |
| Current Assets | $146M | $140M | $160M | $136M | $125M | $127M | $172M | $85M | $92M | $58M | $69M | $78M | $84M | $95M | $86M | $99M | |
| PP&E (Net) | $1M | $669.0K | $759.0K | $828.0K | $912.0K | $988.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $824.0K | · | · | · | $483.0K | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $74.0K | $76.0K | $20.0K | $21.0K | $29.0K | $35.0K | $27.0K | $33.0K | $19.0K | $31.0K | $11.0K | $3M | $3M | $586.0K | $16.0K | $734.0K | |
| Total Assets | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Accounts Payable | $5M | $4M | $3M | $5M | $5M | $2M | $4M | $2M | $1M | $972.0K | $2M | $3M | $2M | $4M | $2M | $456.0K | |
| Accrued Liabilities | $7M | $4M | $6M | $4M | $3M | $4M | $5M | $5M | $3M | $4M | $3M | $3M | $2M | $1M | $3M | $2M | |
| Current Liabilities | $13M | $9M | $11M | $10M | $10M | $7M | $11M | $9M | $6M | $6M | $6M | $7M | $5M | $6M | $6M | $4M | |
| Capital Leases | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | |
| Total Liabilities | $15M | $11M | $13M | $12M | $13M | $10M | $14M | $12M | $10M | $10M | $11M | $12M | $10M | $12M | $11M | $9M | |
| Common Stock | $59.0K | $55.0K | $54.0K | $39.0K | $39.0K | $39.0K | $35.0K | $21.0K | $21.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | |
| Paid-in Capital | $503M | $502M | $499M | $417M | $416M | $415M | $412M | $314M | $313M | $270M | $269M | $267M | $266M | $264M | $263M | $261M | |
| Retained Earnings | $-342M | $-320M | $-302M | $-285M | $-272M | $-257M | $-245M | $-232M | $-221M | $-211M | $-200M | $-190M | $-180M | $-169M | $-160M | $-121M | |
| AOCI | $-363.0K | $-364.0K | $90.0K | $143.0K | $77.0K | $89.0K | $2.0K | $29.0K | · | $-1.0K | $-31.0K | $-165.0K | $-336.0K | $-469.0K | $-688.0K | $-1M | |
| Stockholders' Equity | $161M | $181M | $196M | $132M | $144M | $158M | $167M | $82M | $92M | $58M | $68M | $77M | $85M | $95M | $102M | $139M | |
| Liabilities + Equity | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Shares Outstanding | 59,083,935 | 55,055,582 | 53,587,260 | 38,587,260 | 38,581,863 | 38,577,813 | 35,044,772 | 20,629,772 | 11,364,903 | 11,433,837 | 11,364,903 | 11,364,903 | 11,307,962 | 11,306,753 | 11,267,389 | 11,267,389 |
현금 흐름 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $903.0K | $833.0K | $904.0K | $931.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | |
| Operating Cash Flow | $-15M | $-21M | $-17M | $-12M | $-12M | $-15M | $-9M | $-8M | $-8M | $-10M | $-9M | $-7M | $-9M | $-13M | $-5M | $-5M | |
| CapEx | · | · | $24.0K | $4.0K | $22.0K | $44.0K | $0 | $8.0K | · | · | $0 | $37.0K | $2.0K | $6.0K | $6.0K | $83.0K | |
| Investing Cash Flow | $18M | $-15M | $-27M | $-7M | $-48M | $-58M | $22M | $-29M | $3M | $23M | $15M | $6M | $22M | $10M | $-18M | $19M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $76.0K | · | $27.0K | $0 | $64.0K | $0 | $18.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $-76.0K | · | · | · | $-64.0K | · | · | |
| Financing Cash Flow | $-26.0K | $1M | $81M | $13.0K | $8.0K | $2M | $98M | $0 | $42M | $-76.0K | $0 | $-27.0K | $0 | $-64.0K | $0 | $-18.0K | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | · | · | · | · | $-13M | · | · |
수익성 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1464.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -13.0% | -9.9% | · | -11.1% | -11.6% | -10.1% | · | -12.3% | -9.7% | -12.7% | · | -8.3% | -9.0% | -6.8% | · | -4.7% | |
| ROE | -14.2% | -10.5% | · | -12.4% | -12.7% | -11.0% | · | -14.1% | -10.7% | -14.5% | · | -9.1% | -9.8% | -7.3% | · | -5.0% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.0 | 15.7 | · | 13.7 | 12.8 | 18.0 | · | 9.8 | 16.3 | 10.5 | · | 11.5 | 17.1 | 14.8 | · | 26.6 | |
| Quick Ratio | 10.7 | 15.2 | · | 13.4 | 12.5 | 17.7 | · | 9.4 | 15.9 | 10.0 | · | 10.9 | 16.3 | 13.5 | · | 26.0 |
효율성 1
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-68M | $-58M | · | $-51M | $-48M | $-44M | · | $-42M | $-42M | $-41M | · | $-38M | $-37M | $-36M | · | $-38M | |
| Market Cap | $226M | $287M | · | $168M | $117M | $164M | · | $38M | $24M | $46M | · | $19M | $27M | $35M | · | $33M | |
| P/E | -2.9 | -4.1 | · | -3.0 | -1.9 | -1.9 | · | -0.7 | -0.6 | -1.1 | · | -0.5 | -0.7 | -1.0 | · | -0.9 | |
| P/B | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.2 | |
| P / Tangible Book | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -11.2 | · | · | · | -4.4 | · | · | · | -2.7 | · | · | |
| P / FCF | · | · | · | · | · | -11.1 | · | · | · | · | · | · | · | -2.7 | · | · | |
| Earnings Yield | -34.8% | -24.2% | · | -33.3% | -52.5% | -51.9% | · | -152.5% | -158.2% | -90.8% | · | -200.6% | -135.6% | -102.2% | · | -113.5% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 순이익 | $-57M | $-45M | $-40M | $-66M | $-47M |
| 희석 EPS | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 |
| 당좌 비율 | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-56M | $-36M | $-38M | $-27M | $-35M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 127개의 제출자 · $162.3M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 31 (+4 이전 분기 대비) | 16 (-5 이전 분기 대비) | 39 (-8 이전 분기 대비) | 33 (+10 이전 분기 대비) | +760K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $27,154,562 | 5,207,011 | 16.73% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $11,846,454 | 3,101,166 | 7.30% | 주식 |
| Velan Capital Investment Management LP | $10,866,571 | 2,844,652 | 6.70% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $8,786,508 | 2,300,133 | 5.41% | 주식 |
| Blackstone Inc. | $8,654,263 | 2,265,514 | 5.33% | 주식 |
| ORBIMED ADVISORS LLC | $8,480,400 | 2,220,000 | 5.23% | 주식 |
| Sio Capital Management, LLC | $7,341,551 | 1,921,872 | 4.52% | 주식 |
| ACORN CAPITAL ADVISORS, LLC | $6,693,079 | 1,752,115 | 4.12% | 주식 |
| Integral Health Asset Management, LLC | $5,730,000 | 1,500,000 | 3.53% | 주식 |
| 5AM Venture Management, LLC | $5,232,567 | 1,369,782 | 3.22% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $4,362,540 | 1,141,710 | 2.69% | 주식 |
| STATE STREET CORP | $4,080,887 | 1,068,295 | 2.51% | 주식 |
| Qube Research & Technologies Ltd | $3,993,871 | 1,045,516 | 2.46% | 주식 |
| Balyasny Asset Management L.P. | $3,921,960 | 1,026,691 | 2.42% | 주식 |
| BAKER BROS. ADVISORS LP | $3,711,565 | 971,614 | 2.29% | 주식 |
| ADAR1 Capital Management, LLC | $3,592,756 | 940,512 | 2.21% | 주식 |
| CITADEL ADVISORS LLC | $3,414,045 | 893,729 | 2.10% | 주식 |
| BANK OF AMERICA CORP /DE/ | $3,287,679 | 860,649 | 2.03% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $2,389,918 | 625,633 | 1.47% | 주식 |
| Point72 Asset Management, L.P. | $2,096,920 | 548,932 | 1.29% | 주식 |
| Catalio Capital Management, LP | $1,986,965 | 520,148 | 1.22% | 주식 |
| GOLDMAN SACHS GROUP INC | $1,936,106 | 506,834 | 1.19% | 주식 |
| Walleye Capital LLC | $1,930,750 | 505,432 | 1.19% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,878,130 | 491,657 | 1.16% | 주식 |
| MORGAN STANLEY | $1,833,917 | 480,083 | 1.13% | 주식 |
| UBS Group AG | $1,723,538 | 451,188 | 1.06% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $1,278,489 | 334,683 | 0.79% | 주식 |
| Verdad Advisers, LP | $1,192,791 | 312,249 | 0.73% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1,129,058 | 295,565 | 0.70% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $960,730 | 251,500 | 0.59% | 주식 |
| OPPENHEIMER & CO INC | $910,543 | 238,362 | 0.56% | 주식 |
| Jump Financial, LLC | $775,842 | 203,100 | 0.48% | 주식 |
| CIBC WORLD MARKET INC. | $636,011 | 166,495 | 0.39% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $603,449 | 157,971 | 0.37% | 주식 |
| J. Goldman & Co LP | $515,700 | 135,000 | 0.32% | 주식 |
| SUPERSTRING CAPITAL MANAGEMENT LP | $463,966 | 121,457 | 0.29% | 주식 |
| Fisher Asset Management, LLC | $380,342 | 99,566 | 0.23% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $376,220 | 98,487 | 0.23% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $325,961 | 85,330 | 0.20% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $266,071 | 69,652 | 0.16% | 주식 |
| FMR LLC | $260,012 | 68,066 | 0.16% | 주식 |
| XTX Topco Ltd | $244,281 | 63,948 | 0.15% | 주식 |
| RHUMBLINE ADVISERS | $241,589 | 63,245 | 0.15% | 주식 |
| TRUIST FINANCIAL CORP | $229,200 | 60,000 | 0.14% | 주식 |
| Assenagon Asset Management S.A. | $229,024 | 59,954 | 0.14% | 주식 |
| Trexquant Investment LP | $227,733 | 59,616 | 0.14% | 주식 |
| DEUTSCHE BANK AG\ | $220,464 | 57,713 | 0.14% | 주식 |
| ALPS ADVISORS INC | $217,897 | 57,041 | 0.13% | 주식 |
| AMERIPRISE FINANCIAL INC | $214,863 | 56,247 | 0.13% | 주식 |
| PRUDENTIAL FINANCIAL INC | $193,789 | 50,730 | 0.12% | 주식 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $191,000 | 50,000 | 0.12% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $154,252 | 40,380 | 0.10% | 주식 |
| Alyeska Investment Group, L.P. | $151,753 | 39,726 | 0.09% | 주식 |
| Quadrature Capital Ltd | $150,199 | 39,319 | 0.09% | 주식 |
| Marex Group Ltd | $134,655 | 35,250 | 0.08% | 주식 |
| WINTON GROUP Ltd | $125,296 | 32,800 | 0.08% | 주식 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $113,454 | 29,700 | 0.07% | 주식 |
| MetLife Investment Management, LLC | $108,404 | 28,378 | 0.07% | 주식 |
| MARSHALL WACE, LLP | $106,995 | 28,009 | 0.07% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $93,988 | 18,040 | 0.06% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $92,043 | 24,095 | 0.06% | 주식 |
| WOLVERINE TRADING, LLC | $88,200 | 20,000 | 0.05% | 풋 옵션 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $87,478 | 22,900 | 0.05% | 풋 옵션 |
| CITIGROUP INC | $80,698 | 21,125 | 0.05% | 주식 |
| Jain Global LLC | $80,220 | 21,000 | 0.05% | 주식 |
| Invesco Ltd. | $78,295 | 20,496 | 0.05% | 주식 |
| Vanguard Global Advisers, LLC | $76,885 | 20,127 | 0.05% | 주식 |
| PRELUDE CAPITAL MANAGEMENT, LLC | $74,922 | 19,613 | 0.05% | 주식 |
| EntryPoint Capital, LLC | $73,673 | 19,286 | 0.05% | 주식 |
| LPL Financial LLC | $73,077 | 19,130 | 0.05% | 주식 |
| VANGUARD GROUP INC | $70,479 | 13,223 | 0.04% | 주식 |
| Squarepoint Ops LLC | $69,234 | 18,124 | 0.04% | 주식 |
| IEQ CAPITAL, LLC | $68,489 | 17,929 | 0.04% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $67,114 | 17,569 | 0.04% | 주식 |
| BARCLAYS PLC | $60,665 | 15,881 | 0.04% | 주식 |
| BlackRock, Inc. | $58,950 | 15,432 | 0.04% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $56,834 | 14,878 | 0.04% | 주식 |
| INTECH INVESTMENT MANAGEMENT LLC | $51,807 | 13,562 | 0.03% | 주식 |
| WOLVERINE TRADING, LLC | $51,315 | 11,636 | 0.03% | 주식 |
| Mariner, LLC | $45,441 | 11,899 | 0.03% | 주식 |
| Bank of New York Mellon Corp | $43,877 | 11,486 | 0.03% | 주식 |
| VOYA INVESTMENT MANAGEMENT LLC | $43,812 | 11,469 | 0.03% | 주식 |
| D. E. Shaw & Co., Inc. | $42,452 | 11,113 | 0.03% | 주식 |
| COMMONWEALTH EQUITY SERVICES, LLC | $42,020 | 11,000 | 0.03% | 주식 |
| WELLS FARGO & COMPANY/MN | $41,161 | 10,775 | 0.03% | 주식 |
| Essential Partners LLC | $37,444 | 9,802 | 0.02% | 주식 |
| MERCER GLOBAL ADVISORS INC /ADV | $34,525 | 9,038 | 0.02% | 주식 |
| NORTHERN TRUST CORP | $32,061 | 8,393 | 0.02% | 주식 |
| CWM, LLC | $30,458 | 5,846 | 0.02% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $30,178 | 7,900 | 0.02% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $28,788 | 7,536 | 0.02% | 주식 |
| Tower Research Capital LLC (TRC) | $19,062 | 4,990 | 0.01% | 주식 |
| Legal & General Group Plc | $17,129 | 4,490 | 0.01% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14,645 | 2,811 | 0.01% | 주식 |
| Ameritas Investment Partners, Inc. | $12,598 | 3,298 | 0.01% | 주식 |
| Nuveen, LLC | $9,642 | 2,524 | 0.01% | 주식 |
| Integrated Wealth Concepts LLC | $6,684 | 1,750 | 0.00% | 주식 |
| Arax Advisory Partners | $6,383 | 1,671 | 0.00% | 주식 |
| Russell Investments Group, Ltd. | $6,085 | 1,593 | 0.00% | 주식 |
| ROYAL BANK OF CANADA | $6,000 | 1,577 | 0.00% | 주식 |
회사 내부자 40 명의 내부자 · 16 임원 · 20 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Jesse Shefferman | CEO and President | 2026년 6월 29일 M | 691,832 | 0 | 1 | $-882,160 |
| Timothy P Noyes | President and CEO | 2019년 1월 31일 A | 0 | 0 | 0 | $0 |
| Patrick Fabbio | Chief Financial Officer | 2026년 1월 26일 F | 64,115 | 0 | 0 | $0 |
| Blaine Davis | Chief Financial Officer | 2022년 7월 15일 F | 20,662 | 0 | 0 | $0 |
| George Arthur Eldridge, | Sr VP, CFO, Treasr, Asst Secy | 2019년 1월 18일 A | 29,132 | 0 | 0 | $0 |
| William Conkling | Chief Commercial Officer | 2026년 6월 2일 F | 69,992 | 0 | 0 | $0 |
| Jacqueline Zummo | Chief R&D Officer | 2026년 4월 8일 S | 94,827 | 0 | 2 | $-124,989 |
| Hannah Fry | VP, Controller | 2026년 1월 26일 F | 42,723 | 0 | 0 | $0 |
| Leonardo Viana Nicacio | Chief Medical Officer | 2026년 1월 16일 A | 78,181 | 0 | 0 | $0 |
| Jathin Bandari | Chief Medical Officer | 2024년 1월 19일 A | 56,704 | 0 | 0 | $0 |
| Julio Casoy | Chief Medical Officer | 2020년 1월 9일 A | 45,500 | 0 | 0 | $0 |
| Steven Keith Burke | SVP and Chief Medical Officer | 2019년 3월 15일 G | 26,332 | 0 | 0 | $0 |
| Bradley J Hartman | VP, People | 2019년 1월 18일 A | — | 0 | 0 | $0 |
| Matthew Paul Kowalsky | VP, Legal and Secretary | 2019년 1월 18일 A | 29,479 | 0 | 0 | $0 |
| Scott E. Toner | Senior VP of Commercial | 2019년 1월 18일 A | 23,357 | 0 | 0 | $0 |
| Gottlieb Daniel Philip | VP Corporate Development | 2019년 1월 18일 A | 244 | 0 | 0 | $0 |
| Michael Edward Solomon | 이사 | 2026년 6월 15일 A | 26,500 | 0 | 0 | $0 |
| Jane Huang | 이사 | 2026년 6월 15일 A | — | 0 | 0 | $0 |
| Barry P Flannelly | 이사 | 2026년 6월 15일 A | — | 0 | 0 | $0 |
| Cynthia Smith | 이사 | 2026년 6월 15일 A | — | 0 | 0 | $0 |
| Richard S Levy | 이사 | 2026년 6월 15일 A | 51,000 | 0 | 0 | $0 |
| Roger Garceau | 이사 | 2026년 6월 15일 A | 33,000 | 0 | 0 | $0 |
| Gregory Sargen | 이사 | 2026년 6월 15일 A | 31,000 | 0 | 0 | $0 |
| Luke M Beshar | 이사 | 2026년 6월 15일 A | 198,000 | 0 | 0 | $0 |
| Scott Braunstein | 이사 | 2020년 6월 9일 A | 26,500 | 0 | 0 | $0 |
| John Gordon Freund | 이사 | 2019년 11월 8일 C | 2,175,882 | 0 | 0 | $0 |
| Hubert Birner | 이사 | 2018년 6월 8일 A | 1,943,059 | 0 | 0 | $0 |
| Paul J Hastings | 이사 | 2018년 6월 8일 A | — | 0 | 0 | $0 |
| Scott A Canute | 이사 | 2018년 6월 8일 A | — | 0 | 0 | $0 |
| Garen G Bohlin | 이사 | 2018년 6월 8일 A | 53,312 | 0 | 0 | $0 |
| Jonathan S Leff | 이사 | 2018년 6월 8일 A | — | 0 | 0 | $0 |
| Brendan O'Leary | 이사 | 2016년 6월 9일 A | 1,387,198 | 0 | 0 | $0 |
| Dmitry Kobyzev | 이사 | 2015년 6월 2일 A | 1,165,344 | 0 | 0 | $0 |
| Gregory D Phelps | 이사 | 2015년 6월 2일 A | — | 0 | 0 | $0 |
| Opaleye, L.P. | 10% 소유주 | 2020년 1월 9일 A | 2,208,472 | 0 | 0 | $0 |
| Martin Sebastian Olivo | — | 2021년 6월 10일 P | 14,344 | 0 | 0 | $0 |
| Randall Marshall | — | 2020년 9월 14일 S | 585,600 | 0 | 0 | $0 |
| Timothy Haines | — | 2019년 11월 12일 C | 2,144,517 | 0 | 0 | $0 |
| Abingworth LLP | — | 2019년 11월 12일 C | 2,144,517 | 0 | 0 | $0 |
| Stuart A Kingsley | — | 2018년 6월 8일 A | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 8 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn | 2021년 1월 8일 | — | 최초 제출 | — | SEC |
| Opaleye Management Inc., Opaleye, L.P., James Silverman ×3 제출 서류 | 2020년 9월 25일 | — | 최초 제출 | — | SEC |
| Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn ×6 제출 서류 | 2020년 1월 17일 | — | 최초 제출 | — | SEC |
| Abingworth LLP, Abingworth Bioventures VI, LP | 2020년 1월 17일 | — | 최초 제출 | M&A / 매각 | SEC |
| Abingworth LLP 98-051-8585, Abingworth Bioventures VI, LP 98-040-3543 ×3 제출 서류 | 2019년 11월 14일 | — | 최초 제출 | 이사회 캠페인 | SEC |
| TVM Life Science Ventures VI L.P., TVM Life Science Ventures VI GmbH & Co. KG, TVM Life Science Ventures Management VI L.P., Hubert Birner, Stefan Fischer, Helmut Schuehsler ×2 제출 서류 | 2017년 8월 2일 | — | 최초 제출 | 수동적 투자 | SEC |
| Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Mgmt III, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., James E. Flynn | 2017년 6월 29일 | — | 최초 제출 | 수동적 투자 | SEC |
| Skyline Venture Partners Qualified Purchaser Fund IV, L.P., Skyline Venture Management IV, LLC, John G. Freund, Yasunori Kaneko | 2014년 11월 3일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 22 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0.16% | 55,748 NS | 2026년 5월 31일 | N-PORT |
| IWC · iShares Trust | 0.05% | 175,831 SH | 2026년 8월 8일 | 일간 |
| VFMO · VANGUARD WELLINGTON FUND | 0.03% | 141,979 SH | 2026년 8월 8일 | 일간 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 91,844 NS | 2026년 5월 31일 | N-PORT |
| IWN · iShares Trust | 0.01% | 470,658 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 300,912 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 45,581 SH | 2026년 8월 8일 | 일간 |
| RSSL · Global X Funds | 0.01% | 22,265 NS | 2026년 4월 30일 | N-PORT |
| IWM · iShares Trust | 0.01% | 1,336,607 SH | 2026년 8월 8일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.01% | 179,929 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 2,419 NS | 2026년 5월 31일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 3,715 NS | 2026년 4월 30일 | N-PORT |
| UWM · ProShares Trust | 0.00% | 1,891 NS | 2026년 5월 31일 | N-PORT |
| URTY · ProShares Trust | 0.00% | 1,912 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 48 NS | 2026년 5월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 5,791 NS | 2026년 4월 30일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 18,477 NS | 2026년 4월 30일 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 7,914 NS | 2026년 4월 30일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 20,174 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 586,965 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,657,879 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,185 SH | 2026년 8월 8일 | 일간 |